Literature DB >> 35855711

Walking the thin line-Low-grade oncocytic tumor of kidney: An emerging entity.

Mayur Parkhi1, Debajyoti Chatterjee2, Ashwani Kumar3, Santosh Kumar4.   

Abstract

Low-grade oncocytic tumor (LOT) of kidney is a newly emerging provisional renal tumor entity that carries good prognosis. Here we present a case of low grade oncocytic tumor of kidney in a 68-year-old male with detailed immunohistochemical and ultrastructural description, to add to the existing knowledge about this entity. The importance of documenting low-grade oncocytoma in the literature is its indolent clinical behavior, characteristics gross and microscopic, and immunohistochemical features. The diagnosis of low-grade oncocytoma can be suspected on morphological ground but should be confirmed by immunohistochemistry.
© 2021 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  CD117; Electron Microscopy; Emerging entity; Keratin 7; Low-grade oncocytic tumor

Year:  2021        PMID： 35855711      PMCID： PMC9287666          DOI： 10.1016/j.mjafi.2021.02.003

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


  6 in total

1.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

Review 3.  New and emerging renal entities: a perspective post-WHO 2016 classification.

Authors:  Kiril Trpkov; Ondřej Hes
Journal:  Histopathology       Date:  2019-01       Impact factor: 5.087

4.  Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?

Authors:  Kiril Trpkov; Sean R Williamson; Yuan Gao; Petr Martinek; Liang Cheng; Ankur R Sangoi; Asli Yilmaz; Cheng Wang; Pilar San Miguel Fraile; Delia M Perez Montiel; Stela Bulimbasić; Joanna Rogala; Ondrej Hes
Journal:  Histopathology       Date:  2019-03-21       Impact factor: 5.087

5.  Ultrastructural studies in a series of 18 cases of chromophobe renal cell carcinoma.

Authors:  Santiago Montes Moreno; Isabel Alemany Benítez; Miguel A Martínez González
Journal:  Ultrastruct Pathol       Date:  2005 Sep-Oct       Impact factor: 1.094

6.  Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.

Authors:  Naoto Kuroda; Azusa Tanaka; Tadanori Yamaguchi; Kotaro Kasahara; Keishi Naruse; Yosuke Yamada; Kanako Hatanaka; Nobuo Shinohara; Yoji Nagashima; Shuji Mikami; Mototsugu Oya; Takeru Hamashima; Michal Michal; Ondrej Hes
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.